Development DelaysThe expected start for the Ph2b CSU study has now been pushed out to mid-'26, placing Jasper ~18-24 months behind the competition.
Manufacturing IssuesSome cohorts in BEACON were impacted by an inactive drug product lot, confounding the results and requiring re-dosing and additional patient enrollment.
Workforce ReductionThe company announced a 50% reduction in its workforce, leading to a new headcount of about 22 employees, as a measure to extend the cash runway into 2026.